NeuroVive Pharmaceutical AB Shares float
What is the Shares float of NeuroVive Pharmaceutical AB?
The Shares float of NeuroVive Pharmaceutical AB is 272.606M 551.18%
What is the definition of Shares float?
Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.
= annual shares outstanding - closely held shares
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Shares float of companies in the Miscellaneous sector on LSE compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with shares float similar to NeuroVive Pharmaceutical AB
- Cyrela Brazil Realty SA Empreendimentos e Participações has Shares float of 272.257M 70.81%
- Ningbo Ronbay New Technology Co has Shares float of 272.333M 61.44%
- Fitbit has Shares float of 272.335M 109.58%
- Fitbit A Dl ,0001 has Shares float of 272.335M 111.22%
- Swiss Re AG has Shares float of 272.468M 88.78%
- BeijingWest Industries International has Shares float of 272.495M 47.45%
- NeuroVive Pharmaceutical AB has Shares float of 272.606M 551.18%
- Foxtons Plc has Shares float of 272.908M 85.56%
- NN NV has Shares float of 272.918M 96.59%
- Engineers India has Shares float of 272.932M 48.56%
- Intuit has Shares float of 272.978M 106.77%
- Royal BAM Groep NV has Shares float of 273.032M 99.90%
- Forebase International has Shares float of 273.219M 25.00%